"Protected time" for clinical investigators in medical oncology: The persistent gap between expectation and reality.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 42340000.
- Also identified by DOI 10.1002/cncr.70499 and PMC identifier 13292070.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
“Protected time” in academic oncology is essential for clinical investigators, yet its prevailing definition as “time away from clinic” may no longer reflect the realities of modern cancer research. This commentary examines the growing tension between clinical productivity demands and the operational work of clinical investigation, highlighting the need for broader discussion regarding how protected effort for clinical investigators should be conceptualized, structured, and sustained within academic oncology.